YCT-529, developed by US scientists, moves to early-stage phase 2 trial in New Zealand. Study published in Nature Communications showed it to be 99% effective in preclinical studies.
Islamabad-based think-tank PICSS's new report says Pakistan saw 'pronounced escalation' in violence last year, with 3,413 conflict-related deaths compared to 1,950 in previous year.
Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.
COMMENTS